Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine.

Abdallah Damin AbuKhalilTala Al SheikhSandra MuallemNi'meh Own Al-Shami Hani A Naseef

Published in: Patient preference and adherence (2023)

In this study, we observed a high prevalence of prescribing a PPI in combination with clopidogrel, regardless of the FDA recommendations. No significant increase in cardiovascular events was observed in patients receiving concomitant clopidogrel and PPI therapy.

Keyphrases

cardiovascular events
acute coronary syndrome
percutaneous coronary intervention
antiplatelet therapy
coronary artery disease
primary care
cardiovascular disease
protein protein
risk factors
adverse drug
type diabetes
clinical practice
bone marrow
mesenchymal stem cells
small molecule
replacement therapy